Karl H Thierauch

Title: The Innovations of Karl H Thierauch

Introduction

Karl H Thierauch is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target vascular growth-related diseases. With a total of seven patents to his name, Thierauch's work has the potential to impact various medical conditions.

Latest Patents

Thierauch's latest patents include innovative compounds such as alkynylpyrimidines and their salts. These compounds are designed for pharmaceutical compositions that treat diseases associated with dysregulated vascular growth. His inventions effectively interfere with Tie2 and VEGFR2 signaling pathways, which are crucial in the treatment of conditions like tumors, psoriasis, and various eye diseases. Another significant patent involves VEGFR-2 and VEGFR-3 inhibitory anthranilamide pyridines, which serve as pharmaceutical agents for diseases triggered by persistent angiogenesis.

Career Highlights

Throughout his career, Thierauch has worked with prominent companies in the pharmaceutical industry, including Schering Aktiengesellschaft and Bayer Intellectual Property GmbH. His experience in these organizations has contributed to his expertise in developing innovative medical solutions.

Collaborations

Thierauch has collaborated with notable colleagues such as Ulrich Klar and Helmut Vorbruggen. These partnerships have likely enhanced his research and development efforts in the pharmaceutical field.

Conclusion

Karl H Thierauch's contributions to pharmaceutical innovations demonstrate his commitment to addressing critical health issues through his inventions. His work continues to pave the way for advancements in medical treatments.